Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
University of California, San Diego
Leiden University Medical Center
University of California, San Diego
Verrica Pharmaceuticals Inc.
Eastern Cooperative Oncology Group
University of Kentucky
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Amgen
Catalysis SL
University of Florida
H. Lee Moffitt Cancer Center and Research Institute
Duke University
Assistance Publique - Hôpitaux de Paris
Eli Lilly and Company
University of Kentucky
Eli Lilly and Company
Mereo BioPharma
Acrotech Biopharma Inc.
University of Chicago
Eli Lilly and Company
Eli Lilly and Company
University College, London
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Spanish Oncology Genito-Urinary Group
Novartis
Pfizer
Neovii Biotech
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals
University of Chicago
Washington University School of Medicine
Yale University
Dendreon
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Novartis
Novartis
Novartis
Merck KGaA, Darmstadt, Germany
Novartis
SCRI Development Innovations, LLC
University of Chicago
Samsung Medical Center
Eli Lilly and Company
Amgen
Merck KGaA, Darmstadt, Germany
Sanofi
Steba Biotech S.A.
University Hospitals, Leicester